levofloxacin has been researched along with stearic acid in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (stearic acid) | Trials (stearic acid) | Recent Studies (post-2010) (stearic acid) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 2,532 | 69 | 940 |
| Protein | Taxonomy | levofloxacin (IC50) | stearic acid (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 7.5 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahad, A; Ali, A; Aqil, M; Aslam, M; Baig, MS; Imam, SS | 1 |
1 other study(ies) available for levofloxacin and stearic acid
| Article | Year |
|---|---|
Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Chickens; Disk Diffusion Antimicrobial Tests; Drug Carriers; Drug Delivery Systems; Drug Liberation; Eye; Levofloxacin; Lipids; Nanoparticles; Ophthalmic Solutions; Particle Size; Permeability; Solubility; Stearic Acids; X-Ray Diffraction | 2016 |